Switching and Monitoring Your Patients with RRMS

Predictors of poor prognosis in multiple sclerosis (MS) can include demographic and environmental factors, clinical factors, MRI observations, and biomarkers. Early initiation of appropriate therapy is key when personalizing treatment for relapsing-remitting multiple sclerosis (RRMS), as is having a plan to determine sub-optimal responders, approaches to switching or escalating therapy, and consideration of more aggressive therapies for patients with silent advanced disease or early signs of poor prognosis.

In this CMEOCast podcast, expert faculty discuss treatment initiation options, particularly high efficacy treatments versus escalation, as well as when switching therapies might be necessary and how to take patient- and medication-related issues into consideration.

At the end of this CE activity, participants should be able to:
-Develop individualized treatment plans based on clinical characteristics of patients with RRMS.
-Integrate strategies for delivering patient-centered care in patients with RRMS.
-Assess patients for disease activity and switch when response is suboptimal.

The following learning objectives pertain only to those requesting CNE or CPE credit:
-Evaluate the latest clinical data on the safety and efficacy of current and emerging therapies for RRMS.
-Describe an individualized treatment plan based on clinical characteristics of patients with RRMS.
-Summarize strategies for delivering patient-centered care in patients with RRMS.